HLS Therapeutics Inc. (HLTRF)

HLS Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	114	87	96	235	385	448
Market Cap Growth	9.08%	-9.47%	-59.22%	-38.85%	-14.22%	-26.56%
Enterprise Value	162	135	167	315	463	543
Last Close Price	3.66	2.69	3.84	7.15	11.20	13.30
PS Ratio	2.00	1.53	1.52	3.83	6.41	7.99
PB Ratio	1.70	1.22	0.98	1.88	2.39	2.65
P/FCF Ratio	10.59	10.87	6.09	13.92	23.48	48.18
P/OCF Ratio	10.56	10.85	6.08	13.88	23.41	47.99
EV/Sales Ratio	2.72	2.38	2.64	5.12	7.71	9.67
EV/EBITDA Ratio	9.80	8.99	7.74	15.14	19.78	26.32
EV/FCF Ratio	15.09	16.88	10.57	18.63	28.26	58.31
Debt / Equity Ratio	0.95	0.93	0.90	0.78	0.61	0.65
Debt / EBITDA Ratio	4.05	4.42	4.06	4.66	4.07	5.17
Debt / FCF Ratio	5.94	8.32	5.56	5.76	5.96	11.73
Asset Turnover	0.32	0.31	0.28	0.24	0.21	0.18
Inventory Turnover	1.76	1.58	1.43	1.20	0.99	1.43
Quick Ratio	1.07	1.11	1.22	1.02	1.18	0.93
Current Ratio	1.43	1.57	1.65	1.42	1.58	1.29
Return on Equity (ROE)	-23.08%	-23.25%	-24.69%	-16.50%	-7.95%	-8.82%
Return on Assets (ROA)	-2.28%	-2.60%	-2.87%	-3.26%	-1.35%	-2.42%
Return on Capital (ROIC)	-2.63%	-2.97%	-3.17%	-3.51%	-1.46%	-2.74%
Earnings Yield	-15.82%	-22.63%	-28.70%	-10.03%	-3.41%	-3.42%
FCF Yield	9.44%	9.20%	16.42%	7.18%	4.26%	2.08%
Dividend Yield	-	-	1.97%	2.07%	1.41%	1.18%
Buyback Yield / Dilution	1.10%	1.31%	0.52%	-0.77%	-1.48%	-8.01%
Total Shareholder Return	-	1.31%	2.50%	1.29%	-0.07%	-6.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.